Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Two structurally atypical HEAT domains in the C-terminal portion of human eIF4G support binding to eIF4A and Mnk1.

Bellsolell L, Cho-Park PF, Poulin F, Sonenberg N, Burley SK.

Structure. 2006 May;14(5):913-23.

3.
4.

Initiation factor modifications in the preapoptotic phase.

Morley SJ, Coldwell MJ, Clemens MJ.

Cell Death Differ. 2005 Jun;12(6):571-84. Review.

6.

Perspective: machines for RNAi.

Tomari Y, Zamore PD.

Genes Dev. 2005 Mar 1;19(5):517-29. Review.

7.

Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells.

Avdulov S, Li S, Michalek V, Burrichter D, Peterson M, Perlman DM, Manivel JC, Sonenberg N, Yee D, Bitterman PB, Polunovsky VA.

Cancer Cell. 2004 Jun;5(6):553-63.

8.
9.

Expression of fragments of translation initiation factor eIF4GI reveals a nuclear localisation signal within the N-terminal apoptotic cleavage fragment N-FAG.

Coldwell MJ, Hashemzadeh-Bonehi L, Hinton TM, Morley SJ, Pain VM.

J Cell Sci. 2004 May 15;117(Pt 12):2545-55. Epub 2004 May 5.

10.
11.

Translation factors: in sickness and in health.

Abbott CM, Proud CG.

Trends Biochem Sci. 2004 Jan;29(1):25-31. Review.

PMID:
14729329
12.

Ribosome loading onto the mRNA cap is driven by conformational coupling between eIF4G and eIF4E.

Gross JD, Moerke NJ, von der Haar T, Lugovskoy AA, Sachs AB, McCarthy JE, Wagner G.

Cell. 2003 Dec 12;115(6):739-50.

13.

Phosphorylation screening identifies translational initiation factor 4GII as an intracellular target of Ca(2+)/calmodulin-dependent protein kinase I.

Qin H, Raught B, Sonenberg N, Goldstein EG, Edelman AM.

J Biol Chem. 2003 Dec 5;278(49):48570-9. Epub 2003 Sep 24.

14.

Conducting the initiation of protein synthesis: the role of eIF4G.

Prévôt D, Darlix JL, Ohlmann T.

Biol Cell. 2003 May-Jun;95(3-4):141-56. Review.

PMID:
12867079
15.

RNA-binding activity of translation initiation factor eIF4G1 from Saccharomyces cerevisiae.

Berset C, Zurbriggen A, Djafarzadeh S, Altmann M, Trachsel H.

RNA. 2003 Jul;9(7):871-80.

16.

Translation initiation in cancer: a novel target for therapy.

Meric F, Hunt KK.

Mol Cancer Ther. 2002 Sep;1(11):971-9. Review.

17.

In vitro cleavage of eIF4GI but not eIF4GII by HIV-1 protease and its effects on translation in the rabbit reticulocyte lysate system.

Ohlmann T, Prévôt D, Décimo D, Roux F, Garin J, Morley SJ, Darlix JL.

J Mol Biol. 2002 Apr 19;318(1):9-20.

PMID:
12054764
19.

A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.

Sui G, Soohoo C, Affar el B, Gay F, Shi Y, Forrester WC, Shi Y.

Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5515-20.

20.

Mass spectrometric analysis of the N terminus of translational initiation factor eIF4G-1 reveals novel isoforms.

Bradley CA, Padovan JC, Thompson TL, Benoit CA, Chait BT, Rhoads RE.

J Biol Chem. 2002 Apr 12;277(15):12559-71. Epub 2002 Jan 30.

Supplemental Content

Support Center